Bristol-Myers Squibb Co
Stocks making the biggest premarket moves: CVS, Comcast, Meta, Norwegian Cruise and more
Check out the companies making the biggest moves in premarket trading: CVS Health — The stock popped 7% after the drugstore chain reported an earnings and revenue beat for its second quarter. The company also boosted its adjusted profit outlook, now expecting a range of $6.30 to $6.40 per share for fiscal 2025, up from […]
Read More
Pandemic darlings Moderna, BioNTech are now on two different paths
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or […]
Read More
S&P 500 futures rise after Meta and Microsoft post quarterly beats: Live updates
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 30, 2025. Jeenah Moon | Reuters S&P 500 futures and Nasdaq 100 futures rose on Wednesday evening following solid earnings reports from tech giants Microsoft and Meta Platforms. S&P 500 futures jumped 0.7%, and Nasdaq 100 […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]
Read More
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care […]
Read More
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer
Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its […]
Read More
JPMorgan’s top biotech and pharma picks for the second half
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]
Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]
Read More
Stocks making the biggest moves midday: Tesla, BioNTech, DraftKings, Steel Dynamics and more
Check out the companies making headlines in midday trading. Tesla — Shares of the electric vehicle company dropped 3% after sales in May in declined in several European markets. Reuters reported that Tesla suffered weaker sales in Sweden, France, Spain, Denmark and the Netherlands, but improved in Norway, boosted by the revamped Model Y. Advertising […]
Read More